New Zealand markets open in 2 hours 31 minutes

INmune Bio, Inc. (INMB)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
11.22-0.38 (-3.28%)
As of 03:27PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
155
155
374
181
11
Operating expenses
Research development
20,273
20,273
17,067
20,543
5,918
Selling general and administrative
9,623
9,623
9,258
8,791
6,321
Total operating expenses
29,896
29,896
26,325
29,334
12,239
Operating income or loss
-29,741
-29,741
-25,951
-29,153
-12,228
Total other income/expenses net
-267
-267
-1,348
-1,187
129
Income before tax
-30,008
-30,008
-27,299
-30,340
-12,099
Income from continuing operations
-30,008
-30,008
-27,299
-30,340
-12,099
Net income
-30,008
-30,008
-27,299
-30,340
-12,099
Net income available to common shareholders
-30,008
-30,008
-27,299
-30,340
-12,099
Basic EPS
-1.52
-
-1.52
-1.88
-1.01
Diluted EPS
-1.52
-
-1.52
-1.88
-1.01
Basic average shares
17,962
-
17,927
16,131
11,988
Diluted average shares
17,962
-
17,927
16,131
11,988